Dehlin, M., Jacobsson, L. & Roddy, E. International epidemiology of gout: prevalence, incidence, therapy patterns and threat elements. Nat. Rev. Rheumatol. 16, 380–390 (2020).
Cabău, G., Crișan, T. O., Klück, V., Popp, R. A. & Joosten, L. A. B. Urate-induced immune programming: penalties for gouty arthritis and hyperuricemia. Immunol. Rev. 294, 92–105 (2019).
Choi, H. Ok., McCormick, N. & Yokose, C. Extra comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat. Rev. Rheumatol. 18, 97–111 (2021).
Yang, L. et al. Biomimetic polysaccharide-cloaked lipidic nanovesicles/microassemblies for enhancing the enzymatic exercise and prolonging the motion time for hyperuricemia therapy. Nanoscale 12, 15222–15235 (2020).
Sands, E. et al. Tolerogenic nanoparticles mitigate the formation of anti-drug antibodies towards PEGylated uricase in sufferers with hyperuricemia. Nat. Commun. 13, 272 (2022).
Chen, R. et al. M2 macrophage hybrid membrane-camouflaged focused biomimetic nanosomes to reprogram inflammatory microenvironment for enhanced enzyme-thermo-immunotherapy. Adv. Mater. 35, e2304123 (2023).
Qaseem, A., Harris, R. P. & Forciea, M. A. Administration of acute and recurrent gout: a scientific apply guideline from the American school of physicians. Ann. Intern. Med. 166, 58–68 (2016).
van Durme, C. M. P. G. et al. Non-steroidal anti-inflammatory medication for acute gout. Cochrane Database Sys. Rev. 2021, CD010120 (2021).
Gao, Z.-S. et al. Berberine-loaded M2 macrophage-derived exosomes for spinal twine damage remedy. Acta Biomater. 126, 211–223 (2021).
Hooftman, A. et al. Macrophage fumarate hydratase restrains mtRNA-mediated interferon manufacturing. Nature 615, 490–498 (2023).
Yang, R. et al. Exosomes derived from M2b macrophages attenuate DSS-induced colitis. Entrance. Immunol. 10, 2346 (2019).
Li, H. et al. M2-type exosomes nanoparticles for rheumatoid arthritis remedy by way of macrophage re-polarization. J. Management. Launch 341, 16–30 (2022).
Kalluri, R. & LeBleu, V. S. The biology, operate, and biomedical functions of exosomes. Science 367, eaau6977 (2020).
Zhang, Y. et al. Macrophage membrane biomimetic drug supply system: for irritation focused remedy. J. Drug Goal. 31, 229–242 (2023).
Thamphiwatana, S. et al. Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis administration. Proc. Natl Acad. Sci. USA 114, 11488–11493 (2017).
Solar, T. et al. Amelioration of ulcerative colitis by way of inflammatory regulation by macrophage-biomimetic nanomedicine. Theranostics 10, 10106–10119 (2020).
Pedone, D., Moglianetti, M., De Luca, E., Bardi, G. & Pompa, P. P. Platinum nanoparticles in nanobiomedicine. Chem. Soc. Rev. 46, 4951–4975 (2017).
Lin, A. et al. Self-cascade uricase/catalase mimics alleviate acute gout. Nano Lett. 22, 508–516 (2021).
Zhou, D. et al. Orally administered platinum nanomarkers for urinary monitoring of inflammatory bowel illness. ACS Nano 16, 18503–18514 (2022).
He, S.-B. et al. Sodium alginate modified platinum nanozymes with extremely environment friendly and sturdy oxidase-like exercise for antioxidant capability and evaluation of proanthocyanidins. Entrance. Chem. 8, 654 (2020).
Yu, J. et al. Synergistic enhancement of immunological responses triggered by hyperthermia delicate Pt NPs by way of NIR laser to inhibit most cancers relapse and metastasis. Bioact. Mater. 7, 389–400 (2022).
Yu, H. et al. Biomimetic hybrid membrane-coated xuetongsu assisted with laser irradiation for environment friendly rheumatoid arthritis remedy. ACS Nano 16, 502–521 (2021).
Zhang, M. et al. Superior utility of stimuli-responsive drug supply system for inflammatory arthritis therapy. Mater. Right now Bio 14, 100223 (2022).
Dong, Y., Cao, W. & Cao, J. Therapy of rheumatoid arthritis by phototherapy: advances and views. Nanoscale 13, 14591–14608 (2021).
Bonkowski, M. S. & Sinclair, D. A. Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat. Rev. Mol. Cell Biol. 17, 679–690 (2016).
Singh, A. P. et al. Well being advantages of resveratrol: proof from scientific research. Med. Res. Rev. 39, 1851–1891 (2019).
Fan, W., Chen, S., Wu, X., Zhu, J. & Li, J. Resveratrol relieves gouty arthritis by selling mitophagy to inhibit activation of NLRP3 inflammasomes. J. Inflamm. Res. 14, 3523–3536 (2021).
Schlesinger, N., Padnick-Silver, L. & LaMoreaux, B. Enhancing the response charge to recombinant uricases in sufferers with gout. BioDrugs 36, 95–103 (2022).
Bao, Y.-W., Hua, X.-W., Chen, X. & Wu, F.-G. Platinum-doped carbon nanoparticles inhibit most cancers cell migration beneath delicate laser irradiation: multi-organelle-targeted photothermal remedy. Biomaterials 183, 30–42 (2018).
Wang, D. et al. Erythrocyte–most cancers hybrid membrane camouflaged hole copper sulfide nanoparticles for extended circulation life and homotypic-targeting photothermal/chemotherapy of melanoma. ACS Nano 12, 5241–5252 (2018).
Yuan, D. et al. Macrophage exosomes as pure nanocarriers for protein supply to infected mind. Biomaterials 142, 1–12 (2017).
Cai, R. & Chen, C. The crown and the scepter: roles of the protein corona in nanomedicine. Adv. Mater. 31, e1805740 (2018).
Sies, H. & Jones, D. P. Reactive oxygen species (ROS) as pleiotropic physiological signalling brokers. Nat. Rev. Mol. Cell Biol. 21, 363–383 (2020).
Tardito, S. et al. Macrophage M1/M2 polarization and rheumatoid arthritis: a scientific overview. Autoimmun. Rev. 18, 102397 (2019).
Liu, C. et al. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated concentrating on. Nano Lett. 19, 7836–7844 (2019).
Polanco, J. C., Hand, G. R., Briner, A., Li, C. & Götz, J. Exosomes induce endolysosomal permeabilization as a gateway by which exosomal tau seeds escape into the cytosol. Acta Neuropathol. 141, 235–256 (2021).
Li, Q. et al. Focused immunomodulation remedy for cardiac restore by platelet membrane engineering extracellular vesicles by way of hitching peripheral monocytes. Biomaterials 284, 121529 (2022).
Keller, M. D. et al. Decoy exosomes present safety towards bacterial toxins. Nature 579, 260–264 (2020).
Xu, E., Saltzman, W. M. & Piotrowski-Daspit, A. S. Escaping the endosome: assessing mobile trafficking mechanisms of non-viral automobiles. J. Management. Launch 335, 465–480 (2021).
Qiu, C. et al. Superior methods for overcoming endosomal/lysosomal barrier in nanodrug supply. Analysis 6, 0148 (2023).
Zhang, J. et al. Mitochondrial-targeted supply of polyphenol-mediated antioxidases complexes towards pyroptosis and inflammatory ailments. Adv. Mater. 35, e2208571 (2023).
Wang, Y. et al. Resveratrol mediates mechanical allodynia via modulating inflammatory response by way of the TREM2-autophagy axis in SNI rat mannequin. J. Neuroinflammation 17, 311 (2020).
Tang, Q. et al. Genetically engineering cell membrane-coated BTO nanoparticles for MMP2-activated piezocatalysis-immunotherapy. Adv. Mater. 35, e2300964 (2023).
Wei, Z., Oh, J., Flavell, R. A. & Crawford, J. M. LACC1 bridges NOS2 and polyamine metabolism in inflammatory macrophages. Nature 609, 348–353 (2022).
Zhou, B., Lu, J. G., Siddu, A., Wernig, M. & Südhof, T. C. Synaptogenic impact of APP-Swedish mutation in familial Alzheimer’s illness. Sci. Transl. Med. 14, eabn9380 (2022).
Tang, X. et al. Lengthy noncoding RNA LEENE promotes angiogenesis and ischemic restoration in diabetes fashions. J. Clin. Make investments. 133, e161759 (2023).
Holick, M. F. et al. Genomic or non-genomic? A query concerning the pleiotropic roles of vitamin D in inflammatory-based ailments. Vitamins 15, 767 (2023).
Wang, Ok. et al. Structural mechanism for GSDMD concentrating on by autoprocessed caspases in pyroptosis. Cell 180, 941–955.e920 (2020).
Ference, B. A. et al. Mendelian randomization research of ACLY and heart problems. N. Engl. J. Med. 380, 1033–1042 (2019).
Newman-Tancredi, A., Depoortère, R. Y., Kleven, M. S., Kołaczkowski, M. & Zimmer, L. Translating biased agonists from molecules to drugs: serotonin 5-HT1A receptor useful selectivity for CNS problems. Pharmacol. Ther. 229, 107937 (2022).
Wedell-Neergaard, A.-S. et al. Train-induced adjustments in visceral adipose tissue mass are regulated by IL-6 signaling: a randomized managed trial. Cell Metab. 29, 844–855.e843 (2019).
Nakka, Ok. et al. JMJD3 activated hyaluronan synthesis drives muscle regeneration in an inflammatory setting. Science 377, 666–669 (2022).
Muendlein, H. I. et al. Neutrophils and macrophages drive TNF-induced lethality by way of TRIF/CD14-mediated responses. Sci. Immunol. 7, eadd0665 (2022).
Sobolewski, C. et al. S100A11/ANXA2 belongs to a tumour suppressor/oncogene community deregulated early with steatosis and concerned in irritation and hepatocellular carcinoma growth. Intestine 69, 1841–1854 (2020).
Yu, Z. et al. TRIM41 is required to innate antiviral response by polyubiquitinating BCL10 and recruiting NEMO. Sign Transduct. Goal. Ther. 6, 90 (2021).
Luo, L. et al. Rab8a interacts straight with PI3Kγ to modulate TLR4-driven PI3K and mTOR signalling. Nat. Commun. 5, 4407 (2014).
Andonian, B. J. et al. Altered skeletal muscle metabolic pathways, age, systemic irritation, and low cardiorespiratory health affiliate with enhancements in illness exercise following high-intensity interval coaching in individuals with rheumatoid arthritis. Arthritis Res. Ther. 23, 187 (2021).
Pezone, A. et al. Irritation and DNA harm: trigger, impact or each. Nat. Rev. Rheumatol. 19, 200–211 (2023).
Zhao, Y., Simon, M., Seluanov, A. & Gorbunova, V. DNA harm and restore in age-related irritation. Nat. Rev. Immunol. 23, 75–89 (2022).
Solar, L. et al. Clodronate-loaded liposomal and fibroblast-derived exosomal hybrid system for enhanced drug supply to pulmonary fibrosis. Biomaterials 271, 120761 (2021).
Hu, S. et al. Platelet membrane and stem cell exosome hybrids improve mobile uptake and concentrating on to coronary heart damage. Nano Right now 39, 101210 (2021).
Liang, Y. et al. Chondrocyte-specific genomic enhancing enabled by hybrid exosomes for osteoarthritis therapy. Theranostics 12, 4866–4878 (2022).
Mondal, J. et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic functions. J. Management. Launch 353, 1127–1149 (2023).
Lin, Y. et al. Exosome–liposome hybrid nanoparticles ship CRISPR/Cas9 system in MSCs. Adv. Sci. 5, 1700611 (2018).
Schlesinger, N., Pérez-Ruiz, F. & Lioté, F. Mechanisms and rationale for uricase use in sufferers with gout. Nat. Rev. Rheumatol. 19, 640–649 (2023).
